Michael J. Farrell - Aug 16, 2024 Form 4 Insider Report for RESMED INC (RMD)

Role: Chief Executive Officer
Signature: Michael J. Farrell, Chief Executive Officer
Stock symbol: RMD
Transactions as of: Aug 16, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/16/2024, 10:13 AM
Previous filing: Aug 9, 2024
Next filing: Sep 10, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RMD	ResMed Common Stock	Award	$0	+19.3K	+4.37%	$0.00	460K	Aug 15, 2024	Direct	F1
transaction	RMD	ResMed Common Stock	Award	$0	+4.1K	+0.89%	$0.00	464K	Aug 15, 2024	Direct	F2
holding	RMD	ResMed Common Stock						4.09K	Aug 16, 2024	Lisette and Michael Farrell Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.
F2	Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.

Content

Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.